HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weidong Yin Selected Research

4- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamide

9/2020Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
10/2011Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
1/2010NO-1886 suppresses diet-induced insulin resistance and cholesterol accumulation through STAT5-dependent upregulation of IGF1 and CYP7A1.
9/2006NO-1886 upregulates ATP binding cassette transporter A1 and inhibits diet-induced atherosclerosis in Chinese Bama minipigs.
7/2006Effects of NO-1886 on inflammation-associated cytokines in high-fat/high-sucrose/high-cholesterol diet-fed miniature pigs.
12/2005NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
1/2003Lipoprotein lipase activator NO-1886.
1/2003A lipoprotein lipase-promoting agent, NO-1886, improves glucose and lipid metabolism in high fat, high sucrose-fed New Zealand white rabbits.
1/2002Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weidong Yin Research Topics

Disease

10Insulin Resistance
05/2016 - 01/2003
5Atherosclerosis
09/2006 - 01/2002
3COVID-19
01/2022 - 01/2021
3Neoplasms (Cancer)
02/2020 - 12/2015
3Sleep Initiation and Maintenance Disorders (Insomnia)
03/2014 - 04/2009
3Body Weight (Weight, Body)
04/2009 - 12/2005
2Weight Gain
03/2014 - 04/2009
2Obesity
01/2010 - 12/2005
2Type 2 Diabetes Mellitus (MODY)
01/2010 - 01/2007
1Infections
01/2021
1Hypersensitivity (Allergy)
01/2021
1Hyperglycemia
09/2020
1Hyperlipidemias (Hyperlipidemia)
09/2020
1Poliomyelitis (Polio)
10/2019
1Cognitive Dysfunction
06/2013
1Alzheimer Disease (Alzheimer's Disease)
06/2013
1Hepatitis A (Hepatitis, Infectious)
12/2011
1Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease)
12/2011
1Vascular Diseases (Vascular Disease)
10/2011
1Hepatocellular Carcinoma (Hepatoma)
01/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010
1Hyperinsulinism (Hyperinsulinemia)
01/2010
1Metabolic Diseases (Metabolic Disease)
02/2007
1Human Influenza (Influenza)
09/2006
1Inflammation (Inflammations)
07/2006
1Diabetes Mellitus
07/2006
1Hypertriglyceridemia
01/2003
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2002

Drug/Important Bio-Agent (IBA)

94- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamideIBA
09/2020 - 01/2002
9Sucrose (Saccharose)IBA
03/2014 - 01/2002
8Glucose (Dextrose)FDA LinkGeneric
08/2014 - 01/2002
6Insulin (Novolin)FDA Link
05/2016 - 01/2003
6CholesterolIBA
01/2010 - 01/2002
5VaccinesIBA
01/2021 - 09/2006
5Lipoprotein Lipase (Diacylglycerol Lipase)IBA
09/2020 - 01/2002
4MelatoninIBA
08/2014 - 04/2009
3sinovac COVID-19 vaccineIBA
01/2022 - 01/2021
3LipidsIBA
09/2020 - 01/2002
3N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA
03/2014 - 04/2009
3HDL CholesterolIBA
01/2010 - 09/2006
2Inactivated VaccinesIBA
01/2022 - 01/2021
2Triglycerides (Triacylglycerol)IBA
04/2009 - 01/2002
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2020
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
11/2016
1Immunoglobulin Variable RegionIBA
11/2016
1ExotoxinsIBA
11/2016
1Neutralizing AntibodiesIBA
11/2016
1Immunotoxins (Immunotoxin)IBA
11/2016
1immunotoxin HA22IBA
11/2016
1luzindoleIBA
05/2016
1PolymersIBA
12/2015
1Pharmaceutical PreparationsIBA
12/2015
1Antineoplastic Agents (Antineoplastics)IBA
12/2015
1Palmitic AcidsIBA
08/2014
1Melatonin Receptors (Melatonin Receptor)IBA
03/2014
1Serotonin (5 Hydroxytryptamine)IBA
06/2013
1MT2 Melatonin ReceptorIBA
06/2013
1Conjugate VaccinesIBA
12/2011
1STAT5 Transcription FactorIBA
01/2010
1oxidized low density lipoproteinIBA
01/2010
1LDL CholesterolIBA
01/2010
1AdiponectinIBA
02/2007
1AntigensIBA
09/2006
1AluminumIBA
09/2006
1hydroxide ionIBA
09/2006
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
09/2006
1Apolipoprotein A-I (Apolipoprotein A1)IBA
09/2006
1CytokinesIBA
07/2006
1Uncoupling Protein 3IBA
12/2005
1Dietary CholesterolIBA
10/2004
1Blood Glucose (Blood Sugar)IBA
01/2003

Therapy/Procedure

1Therapeutics
12/2015